• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Daniel M. Geynisman, MD

Latest:

Provider and Patient Burdens of Obtaining Oral Anticancer Medications

Oral anticancer medications are frequently used to treat patients with cancer. We found significant time and energy burdens for clinic staff and patients in obtaining these drugs.


Maureen M. Berg, RN, OCN

Latest:

No Time to Waste: Decreasing Patient Wait Times for Chemotherapy Administration Using Automated Prioritization in an Oncology Pharmacy System

Using a prioritization algorithm in an oncology pharmacy system at the Johns Hopkins University, patient wait times for chemotherapy administration were significantly decreased.


Timothy A. Ducharme, MBA

Latest:

Community Pharmacy Automatic Refill Program Improves Adherence to Maintenance Therapy and Reduces Wasted Medication

Evaluation of a national retail pharmacy automatic refill program for patients on medication for chronic disease demonstrated significantly improved patient adherence and reduced medication oversupply.


Gerry Oster, PhD

Latest:

Is All "Skin in the Game" Fair Game? The Problem With "Non-Preferred" Generics

The authors comment on the growth of drug plans with tiers for "non-preferred" generics, and argue that most are inconsistent with established principles of formulary design.


Eugene Z. Oddone, MD, MHSc

Latest:

Risk Stratification for Return Emergency Department Visits Among High-Risk Patients

The authors examined 2 high-risk classification methods to compare and contrast the patient populations, and to identify the preferred method for predicting subsequent emergency department visits.


Jayant A. Talwalkar, MD

Latest:

Adoption of New Agents and Changes in Treatment Patterns for Hepatitis C: 2010-2014

New hepatitis C medications have been quickly adopted into practice and increased treatment rate. The median out-of-pocket costs of new medications were relatively low.


Neil D. Minkoff, MD

Latest:

Economic Burden of Unintended Pregnancy

Payer considerations regarding unintended pregnancy is discussed by Maria Lopes, MD, MS, and Kevin Stephens Sr., MD, JD.



Susan M. Frayne, MD, MPH

Latest:

Anticoagulation in Atrial Fibrillation: Impact of Mental Illness

Atrial fibrillation patients with mental health conditions are less likely to be eligible for warfarin receipt, and those who are eligible receive warfarin at lower rates.


Maurizio Fava, MD

Latest:

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings

Pharmacy and medical claims data showed that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.


Briar L. Ertz-Berger, MD, MPH

Latest:

Pilot of Urgent Care Center Evaluation for Acute Coronary Syndrome

A formal protocol for urgent care center evaluation of potential acute coronary syndrome safely precluded emergency department visits among 84% of those eligible.










David Bai

Latest:

Calcaneal Quantitative Ultrasound May Serve as a Prescreening Tool for Osteoporosis

Calcaneal quantitative ultrasound (QUS) has comparable diagnostic accuracy as dual-energy x-ray absorptiometry (DXA), the gold standard for diagnosing osteoporosis. Although it cannot replace DXA for diagnosing osteoporosis, it can be used as an effective prescreening tool prior to a DXA scan, researchers said it a recent study comparing the performance of the 2 screening methods.


Christine M. Colombo, MBA

Latest:

Medical Homes: Cost Effects of Utilization by Chronically Ill Patients

A longitudinal case-control design was used to evaluate the effects of the patient-centered medical home model on medical costs and utilization among chronically ill patients.



Sharon S. Lieberman-Blum, PharmD

Latest:

Ezetimibe 5 and 10 mg for Lowering LDL-C: Potential Billion-Dollar Savings With Improved Tolerability

This retrospective study strongly suggests that splitting a 10-mg ezetimibe tablet yields a 5-mg dose that is clinically equivalent to the 10-mg dose.


Sara M. Eltaki, PharmD, B

Latest:

Building Partnerships Between a College of Pharmacy and ACOs: Development of the ACORN SEED

To promote future partnerships among colleges of pharmacy and accountable care organizations, this article describes several initial challenges to partnership formation, including those related to agenda setting and resource utilization.


Barbara G. Vickrey, MD, MPH

Latest:

A Dementia Care Management Intervention: Which Components Improve Quality?

Specifically trained care managers are essential for quality gains from a dementia care management program; even higher quality accrues with coordination across community and primary care.




Lindsey Jeanne Leininger, PhD

Latest:

Health-Related Quality of Life in High-Cost, High-Need Populations

Health-related quality of life is a psychometrically sound outcome measure for high-cost, high-need populations. Unlike health care spending, it does not exhibit mean reversion.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.